Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Orthofix Medical Inc. (OFIX)
|
Add to portfolio |
|
|
|
| Price: |
$32.37
| | Metrics |
| OS: |
36.7
|
M
| |
-31
|
% ROE
|
| Market cap: |
$1.19
|
B
| |
-48
|
% ROIC
|
|
Net cash:
|
$37.6
|
M
| |
$1.02
|
per share
|
|
EV:
|
$1.15
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($192)
|
M
| |
|
|
| EPS |
($41.28)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 460.7 | 460.7 | 464.5 | 464.5 | 406.6 | 460.0 | 453.0 | 433.8 |
| Revenue growth | -0.8% | -0.8% | 14.2% | | -11.6% | 1.5% | 4.4% | 5.9% |
| Cost of goods sold | 123.5 | 123.5 | 114.9 | 114.9 | 101.9 | 100.6 | 96.6 | 93.0 |
| Gross profit | 337.2 | 337.2 | 349.6 | 349.6 | 304.7 | 359.3 | 356.4 | 340.8 |
| Gross margin | 73.2% | 73.2% | 75.3% | 75.3% | 74.9% | 78.1% | 78.7% | 78.6% |
| Sales and marketing | 228.8 | 228.8 | 221.3 | 221.3 | 204.4 | 223.7 | 205.5 | 198.4 |
| Research and development | | 49.1 | | 49.6 | | 34.6 | 33.2 | 29.7 |
| General and administrative | | 80.0 | | 69.4 | | 85.6 | 83.3 | 71.9 |
| EBITA | -6.3 | -13.3 | -3.0 | -8.3 | 8.6 | -11.8 | 32.8 | 42.6 |
| EBITA margin | -1.4% | -2.9% | -0.7% | -1.8% | 2.1% | -2.6% | 7.2% | 9.8% |
| Amortization of intangibles | 9.4 | | 9.4 | | 11.2 | 7.0 | 2.7 | 1.8 |
| EBIT | -15.7 | -13.3 | -12.4 | -8.3 | -2.6 | -18.8 | 30.1 | 40.8 |
| EBIT margin | -3.4% | -2.9% | -2.7% | -1.8% | -0.6% | -4.1% | 6.6% | 9.4% |
| Pre-tax income | -17.7 | -17.7 | -13.5 | -13.5 | -0.4 | -27.0 | 22.9 | 36.4 |
| Income taxes | 2.0 | 2.0 | 24.9 | 24.9 | -2.9 | 1.4 | 9.1 | 29.1 |
| Tax rate | | | | | 784.0% | | 39.7% | 80.0% |
| Net income | -19.7 | -19.7 | -38.4 | -38.4 | 2.5 | -28.5 | 13.8 | 6.2 |
| Net margin | -4.3% | -4.3% | -8.3% | -8.3% | 0.6% | -6.2% | 3.0% | 1.4% |
| |
| Diluted EPS | ($0.98) | ($0.98) | ($1.95) | ($1.95) | $0.13 | ($1.51) | $0.73 | $0.39 |
| Shares outstanding (diluted) | 20.1 | 20.1 | 19.7 | 19.7 | 19.4 | 18.9 | 18.9 | 18.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|